Concepedia

Feasibility and cost-effectiveness of standardised second-line drug treatment for chronic tuberculosis patients: a national cohort study in Peru

Pedro Suarez, Katherine Floyd, J. Portocarrero, Elisabetta Rapiti, Gilbert Ramos, César Antonio Bonilla-Asalde, Isabel Aranda, Christopher Dye, Mario Raviǵlione, Marcos Espinal

The Lancet · 2002 · 214 citations · 12 references

DOI

Concepts

References

12

The Role of Cost-effectiveness Analysis in Health and Medicine

Louise B. Russell · JAMA · 1996 · 1.2K citations

, , +17

Global Surveillance for Antituberculosis-Drug Resistance, 1994–1997

Ariel Pablos-Méndez, Mario Raviǵlione, A László et al. · New England Journal of Medicine · 1998 · 820 citations · Full text

, , +17

Treatment of 171 Patients with Pulmonary Tuberculosis Resistant to Isoniazid and Rifampin

Marian Goble, Michael D. Iseman, Lorie A. Madsen et al. · New England Journal of Medicine · 1993 · 705 citations · Full text

, , +13

Global Trends in Resistance to Antituberculosis Drugs

Marcos Espinal, A László, Lone Simonsen et al. · New England Journal of Medicine · 2001 · 675 citations

, , +17

Standard Short-Course Chemotherapy for Drug-Resistant Tuberculosis

Marcos Espinal, Sang‐Jae Kim, Pedro Suarez et al. · JAMA · 2000 · 510 citations

, , +17